It’s getting easier to manage diabetes for the approximately 2.6 million people in the U.S. who need multiple daily insulin injections as Abbott’s much-anticipated partnership with medical device startup Bigfoot Biomedical comes to life.
Bigfoot has received clearance from the U.S. Food and Drug Administration for the Bigfoot Unity Diabetes Management system. This first-of-its-kind system features smart pen caps for disposable insulin pens — injection devices, about the size of a marker, that people with diabetes use to inject insulin — which integrate with Abbott’s world-leading FreeStyle Libre 2 technology.
Here’s how it works.
Learn more about how Abbott and its partners can help you manage your diabetes.
Data on file. Bigfoot Biomedical.
Based on available products for multiple daily injection therapy of insulin as of April 2021.
Data on file, Abbott Diabetes Care. Data based on the number of users worldwide for the FreeStyle Libre portfolio compared to the number of users for other leading personal use, sensor-based glucose monitoring systems.
Subscribe to the Abbott Channel and receive automatic updates: https://www.youtube.com/channel/UC346EX3v26ACsjLhe-HwHDg/?sub_confirmation=1
– REVOLUTIONIZING CGM WITH FREESTYLE LIBRE. – https://www.youtube.com/watch?v=y8YVGYvvino&list=PLRm37zU0kWR6xYs941i2RIApgwqPH1-Hd&index=4
– FREESTYLE LIBRE 2: THE NEXT GENERATION OF DIABETES CARE IS HERE. – https://www.youtube.com/watch?v=xVBM5029YuY&list=PLRm37zU0kWR6xYs941i2RIApgwqPH1-Hd&index=2
Find out more about us and our products on http://www.abbott.com/
Connect with us on …
Video Rating: / 5